Kalexate

Active Ingredient(s): Sodium Polystyrene Sulfonate
FDA Approved: * March 30, 2009
Pharm Company: * KVK TECH
Category: Potassium Levels

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Kalexate Overview

Polystyrene sulfonates are a group of medications used to treat high blood potassium.[1] Effects generally take hours to days.[1] They are also used to remove potassium, calcium, and sodium from solutions in technical applications. Common side effects include loss of appetite, gastrointestinal upset, constipation, and low blood calcium.[1] These polymers are derived from polystyrene by the addition of sulfonate functional groups. Sodium polystyr...

Read more Kalexate Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Kionex

Recent Kalexate Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Sodium Polystyrene Sulfonate
  • Powder: 15gm/bot, 453.6gm/bot, 454g, 454gm/bot
  • Powder for Reconstitution: 100%, 15g/60ml, 4.1meq/g
  • Suspension: 15g/60ml, 15gm/60ml, 30g/120ml, 50g/200ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Sodium Polystyrene Sulfonate or a similar ingredient: (3 results)